Vortioxetine Synthesis Using Cyclic Amide Solvent
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for preparing vortioxetine, an antidepressant, suffer from low yield and purity, requiring repeated purification steps and the use of costly reagents and solvents, making them industrially inefficient.
Innovation Solution
A process involving the reaction of 2-((2,4-dimethylphenyl)thio)aniline with bis(2-alkyl)amine in a cyclic amide solvent at controlled temperatures, eliminating the need for toxic solvents and costly reagents, and achieving high yield and purity without repetitive purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional processes are used for preparing vortioxetine, then the reaction can proceed with available reagents, but the yield and purity are low requiring repeated purification steps
Solution Approach 1:
The patent changes the reaction parameters by using a specific cyclic amide solvent (N-methyl-2-pyrrolidone) and controlling temperature (80-180°C) to optimize both yield and purity. This parameter optimization eliminates the need for repeated purification steps while achieving 70% yield and 99% purity simultaneously.
Solution Approach 2:
The patent replaces costly reagents and coupling agents with simpler, more economical reactants. The process uses readily available starting materials that do not require expensive metal catalysts or phosphine ligands, reducing overall process cost while maintaining high efficiency.
2Reliability
If costly reagents and coupling agents are used, then the reaction can proceed, but the process cost increases making it industrially infeasible
Solution Approach 1:
The patent eliminates expensive reagents such as metal catalysts and phosphine ligands by using a direct reaction approach in cyclic amide solvent. The process achieves high reliability without requiring costly coupling agents, making it economically viable for industrial production.
Solution Approach 2:
The patent removes unnecessary costly components from the reaction system. By extracting out the need for expensive reagents and coupling agents, the process achieves the same synthetic transformation through a more economical pathway using simple heating in cyclic amide solvent.
3Manufacturing precision
If multiple purification steps are implemented, then purity can be improved, but the operational complexity and time increase
Solution Approach 1:
The patent optimizes reaction parameters including temperature control (80-180°C) and solvent selection (cyclic amide) to achieve such high purity (99%) that multiple purification steps become unnecessary. The single reaction step produces the desired product with minimal impurities.
Solution Approach 2:
The patent extracts out the need for complex purification equipment and multiple processing steps. The reaction system is designed to produce high-purity product directly, eliminating the requirement for repeated crystallization or chromatography operations.
4Productivity
If conventional solvents and reagents are used, then the reaction can proceed, but toxic and costly materials are required
Solution Approach 1:
The patent replaces toxic conventional solvents with cyclic amide solvents that are less hazardous. The process uses simpler, more environmentally friendly reagents that achieve the same synthetic transformation without requiring toxic metal catalysts or harmful coupling agents.
Solution Approach 2:
The patent converts a potentially harmful process into a beneficial one by selecting reaction conditions that inherently produce high purity product. The cyclic amide solvent system promotes selective reaction that minimizes toxic byproducts and eliminates the need for additional purification that would remove harmful contaminants.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves a 70% yield with over 99% purity, reducing costs and operational complexity, and is scalable for commercial production.
Implementation Method 1
reacting the compound (II) with the compound (Ma) or its salt in a cyclic amide solvent
Data Source
AI summary
The present invention provides an improved process for preparation of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine; commonly known as vortioxetine (referred to as the compound (I)) and pharmaceutically acceptable salts thereof; wherein the process comprises reaction of 2-((2,4-dimethylphenyl)thio)aniline (II) with bis(2-alkyl)amine (IIIa) or its salt in the presence of a cyclic amide solvent.